ISR — ISR Immune System Regulation Holding AB (publ) Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for ISR Immune System Regulation Holding AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -20.9 | -28.9 | -29.9 | -78.6 | -206 |
| Non-Cash Items | 0.187 | 0.187 | 0.466 | 0.002 | 0 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.38 | -1.38 | -21 | 11.2 | 112 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -17.3 | -30.1 | -50.5 | -67.4 | -93.7 |
| Other Investing Cash Flow Items | 0 | — | — | — | — |
| Sale of Business | |||||
| Cash from Investing Activities | 0 | — | — | — | — |
| Financing Cash Flow Items | — | — | -1.24 | -3.75 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 34 | 19.8 | 67.3 | 82.4 | 40.2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 16.7 | -10.3 | 16.8 | 15 | -53.5 |